From Morphology to Biomarkers: Optical Coherence Tomography in Corneal Disease
Lanxing Fu, Yvonne H.-L. Luo, Nick Kopsachilis, Matteo Capobianco, Irene Gattazzo, Francesco Cappellani, Fabiana D’Esposito, Caterina Gagliano, Marco Zeppieri · 2026
Read From Morphology to Biomarkers: Optical Coherence Tomography in Corneal Disease by Lanxing Fu, Yvonne H.-L. Luo, Nick Kopsachilis, Matteo Capobianco, Irene Gattazzo, Francesco Cappellani, Fabiana D’Esposito, Caterina Gagliano, Marco Zeppieri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13605135.txt.
Description
Fu and co-authors review how OCT imaging of the cornea moved from pretty pictures to measured biomarkers, in a review paper from 2026. OCT, short for optical coherence tomography, scans the cornea without touching it and shows its layers in fine detail. Clinicians use it across chronic corneal disease.
The review tracks how traits like surface layer thickness, inner layer glow patterns, and thickness maps turn into numbers. Those numbers grade disease severity, track change over time, and judge whether treatment works. Gains show in conditions such as keratoconus, stubborn corneal infection, and inherited dystrophies. Automated analysis and AI add new power for finding markers. The authors urge trials that join imaging numbers with long-term patient data.
Catalog record
| CREATOR | Lanxing Fu, Yvonne H.-L. Luo, Nick Kopsachilis, Matteo Capobianco, Irene Gattazzo, Francesco Cappellani, Fabiana D’Esposito, Caterina Gagliano, Marco Zeppieri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |